{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T16:47:41Z","timestamp":1794329261152,"version":"4.9.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000053","name":"U.S. Department of Health & Human Services | NIH | National Eye Institute","doi-asserted-by":"publisher","award":["UG1EY027726"],"award-info":[{"award-number":["UG1EY027726"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"U.S. Department of Health & Human Services | NIH | National Eye Institute","doi-asserted-by":"publisher","award":["UG1EY027725"],"award-info":[{"award-number":["UG1EY027725"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-56461-1","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T10:03:44Z","timestamp":1741082624000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Cultivated autologous limbal epithelial cell (CALEC) transplantation for limbal stem cell deficiency: a phase I\/II clinical trial of the first xenobiotic-free, serum-free, antibiotic-free manufacturing protocol developed in the US"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5059-608X","authenticated-orcid":false,"given":"Ula V.","family":"Jurkunas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron R.","family":"Kaufman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1340-6758","authenticated-orcid":false,"given":"Jia","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Ayala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4249-2467","authenticated-orcid":false,"given":"Maureen","family":"Maguire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lassana","family":"Samarakoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynette K.","family":"Johns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5186-068X","authenticated-orcid":false,"given":"Mohit","family":"Parekh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Gauthier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helene","family":"Negre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kit L.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego E.","family":"Hernandez Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Daley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5732-5100","authenticated-orcid":false,"given":"Reza","family":"Dana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5205-3003","authenticated-orcid":false,"given":"Myriam","family":"Armant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5526-4669","authenticated-orcid":false,"given":"Jerome","family":"Ritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,4]]},"reference":[{"key":"56461_CR1","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/eye.1989.22","volume":"3","author":"SC Tseng","year":"1989","unstructured":"Tseng, S. C. Concept and application of limbal stem cells. Eye (Lond.) 3, 141\u2013157 (1989).","journal-title":"Eye (Lond.)"},{"key":"56461_CR2","first-page":"721","volume":"89","author":"WM Townsend","year":"1991","unstructured":"Townsend, W. M. The limbal palisades of Vogt. Trans. Am. Ophthalmol. Soc. 89, 721\u2013756 (1991).","journal-title":"Trans. Am. Ophthalmol. Soc."},{"key":"56461_CR3","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1097\/ICO.0000000000001820","volume":"38","author":"SX Deng","year":"2019","unstructured":"Deng, S. X. et al. Global Consensus on Definition, Classification, Diagnosis, and Staging of Limbal Stem Cell Deficiency. Cornea 38, 364\u2013375 (2019).","journal-title":"Cornea"},{"key":"56461_CR4","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1097\/ICO.0000000000002358","volume":"39","author":"SX Deng","year":"2020","unstructured":"Deng, S. X. et al. Global Consensus on the Management of Limbal Stem Cell Deficiency. Cornea 39, 1291\u20131302 (2020).","journal-title":"Cornea"},{"key":"56461_CR5","doi-asserted-by":"crossref","unstructured":"Masood, F. et al. Therapeutic Strategies for Restoring Perturbed Corneal Epithelial Homeostasis in Limbal Stem Cell Deficiency: Current Trends and Future Directions. Cells 11 (2022).","DOI":"10.3390\/cells11203247"},{"key":"56461_CR6","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0161-6420(89)32833-8","volume":"96","author":"KR Kenyon","year":"1989","unstructured":"Kenyon, K. R. & Tseng, S. C. Limbal autograft transplantation for ocular surface disorders. Ophthalmology 96, 709\u2013722 (1989). discussion 722-703.","journal-title":"Ophthalmology"},{"key":"56461_CR7","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1056\/NEJMoa0905955","volume":"363","author":"P Rama","year":"2010","unstructured":"Rama, P. et al. Limbal stem-cell therapy and long-term corneal regeneration. N. Engl. J. Med. 363, 147\u2013155 (2010).","journal-title":"N. Engl. J. Med."},{"key":"56461_CR8","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1080\/08820538.2017.1353834","volume":"33","author":"J Yin","year":"2018","unstructured":"Yin, J. & Jurkunas, U. Limbal Stem Cell Transplantation and Complications. Semin. Ophthalmol. 33, 134\u2013141 (2018).","journal-title":"Semin. Ophthalmol."},{"key":"56461_CR9","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1001\/jamaophthalmol.2020.1120","volume":"138","author":"Q Le","year":"2020","unstructured":"Le, Q., Chauhan, T., Yung, M., Tseng, C. H. & Deng, S. X. Outcomes of Limbal Stem Cell Transplant: A Meta-analysis. JAMA Ophthalmol. 138, 660\u2013670 (2020).","journal-title":"JAMA Ophthalmol."},{"key":"56461_CR10","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1136\/bjophthalmol-2011-301164","volume":"96","author":"VS Sangwan","year":"2012","unstructured":"Sangwan, V. S., Basu, S., MacNeil, S. & Balasubramanian, D. Simple limbal epithelial transplantation (SLET): a novel surgical technique for the treatment of unilateral limbal stem cell deficiency. Br. J. Ophthalmol. 96, 931\u2013934 (2012).","journal-title":"Br. J. Ophthalmol."},{"key":"56461_CR11","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/S0140-6736(96)11188-0","volume":"349","author":"G Pellegrini","year":"1997","unstructured":"Pellegrini, G. et al. Long-term restoration of damaged corneal surfaces with autologous cultivated corneal epithelium. Lancet (Lond., Engl.) 349, 990\u2013993 (1997).","journal-title":"Lancet (Lond., Engl.)"},{"key":"56461_CR12","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1007\/s40123-020-00305-2","volume":"9","author":"AE Ghareeb","year":"2020","unstructured":"Ghareeb, A. E., Lako, M. & Figueiredo, F. C. Recent Advances in Stem Cell Therapy for Limbal Stem Cell Deficiency: A Narrative Review. Ophthalmol. Ther. 9, 809\u2013831 (2020).","journal-title":"Ophthalmol. Ther."},{"key":"56461_CR13","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.jtos.2016.02.006","volume":"14","author":"J Vazirani","year":"2016","unstructured":"Vazirani, J. et al. Surgical Management of Bilateral Limbal Stem Cell Deficiency. Ocul. Surf. 14, 350\u2013364 (2016).","journal-title":"Ocul. Surf."},{"key":"56461_CR14","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ajo.2022.03.015","volume":"239","author":"U Jurkunas","year":"2022","unstructured":"Jurkunas, U., Johns, L. & Armant, M. Cultivated Autologous Limbal Epithelial Cell Transplantation: New Frontier in the Treatment of Limbal Stem Cell Deficiency. Am. J. Ophthalmol. 239, 244\u2013268 (2022).","journal-title":"Am. J. Ophthalmol."},{"key":"56461_CR15","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adg6470","volume":"9","author":"UV Jurkunas","year":"2023","unstructured":"Jurkunas, U. V. et al. Cultivated autologous limbal epithelial cell (CALEC) transplantation: Development of manufacturing process and clinical evaluation of feasibility and safety. Sci. Adv. 9, eadg6470 (2023).","journal-title":"Sci. Adv."},{"key":"56461_CR16","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.ophtha.2023.01.016","volume":"130","author":"Y Oie","year":"2023","unstructured":"Oie, Y. et al. Clinical Trial of Autologous Cultivated Limbal Epithelial Cell Sheet Transplantation for Patients with Limbal Stem Cell Deficiency. Ophthalmology 130, 608\u2013614 (2023).","journal-title":"Ophthalmology"},{"key":"56461_CR17","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1136\/bjophthalmol-2011-300352","volume":"95","author":"VS Sangwan","year":"2011","unstructured":"Sangwan, V. S. et al. Clinical outcomes of xeno-free autologous cultivated limbal epithelial transplantation: a 10-year study. Br. J. Ophthalmol. 95, 1525\u20131529 (2011).","journal-title":"Br. J. Ophthalmol."},{"key":"56461_CR18","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1111\/j.1395-3907.2004.00285.x","volume":"82","author":"T Nakamura","year":"2004","unstructured":"Nakamura, T., Inatomi, T., Sotozono, C., Koizumi, N. & Kinoshita, S. Successful primary culture and autologous transplantation of corneal limbal epithelial cells from minimal biopsy for unilateral severe ocular surface disease. Acta ophthalmol. Scandinavica 82, 468\u2013471 (2004).","journal-title":"Acta ophthalmol. Scandinavica"},{"key":"56461_CR19","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.2147\/OPTH.S89700","volume":"9","author":"JD Bartlett","year":"2015","unstructured":"Bartlett, J. D., Keith, M. S., Sudharshan, L. & Snedecor, S. J. Associations between signs and symptoms of dry eye disease: a systematic review. Clin. Ophthalmol. 9, 1719\u20131730 (2015).","journal-title":"Clin. Ophthalmol."},{"key":"56461_CR20","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1097\/01.ico.0000133997.07144.9e","volume":"23","author":"KK Nichols","year":"2004","unstructured":"Nichols, K. K., Nichols, J. J. & Mitchell, G. L. The lack of association between signs and symptoms in patients with dry eye disease. Cornea 23, 762\u2013770 (2004).","journal-title":"Cornea"},{"key":"56461_CR21","unstructured":"Tawfik, A. et al. Association of Dry Eye Symptoms and Signs in Patients with Dry Eye Disease. Ophthal. Epidemiol, 1\u20139 (2023)."},{"key":"56461_CR22","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1097\/ICO.0000000000001260","volume":"36","author":"AY Cheung","year":"2017","unstructured":"Cheung, A. Y., Sarnicola, E. & Holland, E. J. Long-Term Ocular Surface Stability in Conjunctival Limbal Autograft Donor Eyes. Cornea 36, 1031\u20131035 (2017).","journal-title":"Cornea"},{"key":"56461_CR23","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1136\/bjophthalmol-2019-314081","volume":"104","author":"SS Shanbhag","year":"2020","unstructured":"Shanbhag, S. S. et al. Autologous limbal stem cell transplantation: a systematic review of clinical outcomes with different surgical techniques. Br. J. Ophthalmol. 104, 247\u2013253 (2020).","journal-title":"Br. J. Ophthalmol."},{"key":"56461_CR24","doi-asserted-by":"publisher","first-page":"3156","DOI":"10.1073\/pnas.061032098","volume":"98","author":"G Pellegrini","year":"2001","unstructured":"Pellegrini, G. et al. p63 identifies keratinocyte stem cells. Proc. Natl Acad. Sci. USA 98, 3156\u20133161 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"56461_CR25","doi-asserted-by":"crossref","unstructured":"Amin, S., et al. The Limbal Niche and Regenerative Strategies. Vision (Basel) 5 (2021).","DOI":"10.3390\/vision5040043"},{"key":"56461_CR26","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1038\/eye.2008.379","volume":"23","author":"L Liang","year":"2009","unstructured":"Liang, L., Sheha, H., Li, J. & Tseng, S. C. Limbal stem cell transplantation: new progresses and challenges. Eye (Lond.) 23, 1946\u20131953 (2009).","journal-title":"Eye (Lond.)"},{"key":"56461_CR27","doi-asserted-by":"publisher","first-page":"8086269","DOI":"10.1155\/2018\/8086269","volume":"2018","author":"M Sacchetti","year":"2018","unstructured":"Sacchetti, M., Rama, P., Bruscolini, A. & Lambiase, A. Limbal Stem Cell Transplantation: Clinical Results, Limits, and Perspectives. Stem cells Int. 2018, 8086269 (2018).","journal-title":"Stem cells Int."},{"key":"56461_CR28","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.exer.2005.02.016","volume":"81","author":"U Schl\u00f6tzer-Schrehardt","year":"2005","unstructured":"Schl\u00f6tzer-Schrehardt, U. & Kruse, F. E. Identification and characterization of limbal stem cells. Exp. Eye Res 81, 247\u2013264 (2005).","journal-title":"Exp. Eye Res"},{"key":"56461_CR29","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/ICL.0000000000000908","volume":"48","author":"Z Akgun","year":"2022","unstructured":"Akgun, Z., Palamar, M., Egrilmez, S., Yagci, A. & Selver, O. B. Clinical Characteristics and Severity Distribution of Tertiary Eye Center Attendance by Ocular Chemical Injury Patients. Eye Contact Lens 48, 295\u2013299 (2022).","journal-title":"Eye Contact Lens"},{"key":"56461_CR30","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.4103\/IJO.IJO_3330_22","volume":"71","author":"A Kate","year":"2023","unstructured":"Kate, A. et al. Demographic profile and clinical characteristics of patients presenting with acute ocular burns. Indian J. Ophthalmol. 71, 2694\u20132703 (2023).","journal-title":"Indian J. Ophthalmol."},{"key":"56461_CR31","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1179\/oeh.1998.4.3.199","volume":"4","author":"AE Vergara","year":"1998","unstructured":"Vergara, A. E. & Fuortes, L. Surveillance and epidemiology of occupational pesticide poisonings on banana plantations in Costa Rica. Int J. Occup. Environ. Health 4, 199\u2013201 (1998).","journal-title":"Int J. Occup. Environ. Health"},{"key":"56461_CR32","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1016\/j.burns.2019.11.007","volume":"46","author":"JM Quesada","year":"2020","unstructured":"Quesada, J. M., Lloves, J. M. & Delgado, D. V. Ocular chemical burns in the workplace: Epidemiological characteristics. Burns 46, 1212\u20131218 (2020).","journal-title":"Burns"},{"key":"56461_CR33","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jtos.2021.02.006","volume":"20","author":"AA Ahmmed","year":"2021","unstructured":"Ahmmed, A. A., Ting, D. S. J. & Figueiredo, F. C. Epidemiology, economic and humanistic burdens of Ocular Surface Chemical Injury: A narrative review. Ocul. Surf. 20, 199\u2013211 (2021).","journal-title":"Ocul. Surf."},{"key":"56461_CR34","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1001\/archopht.116.4.431","volume":"116","author":"SC Tseng","year":"1998","unstructured":"Tseng, S. C., Prabhasawat, P., Barton, K., Gray, T. & Meller, D. Amniotic membrane transplantation with or without limbal allografts for corneal surface reconstruction in patients with limbal stem cell deficiency. Arch. Ophthalmol. (Chic., Ill.: 1960) 116, 431\u2013441 (1998).","journal-title":"Arch. Ophthalmol. (Chic., Ill.: 1960)"},{"key":"56461_CR35","first-page":"221","volume":"21","author":"MA Lemp","year":"1995","unstructured":"Lemp, M. A. Report of the National Eye Institute\/Industry workshop on Clinical Trials in Dry Eyes. CLAO J.: Off. Publ. Contact Lens Assoc. Ophthalmol. Inc. 21, 221\u2013232 (1995).","journal-title":"CLAO J.: Off. Publ. Contact Lens Assoc. Ophthalmol. Inc."},{"key":"56461_CR36","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1001\/archophthalmol.2009.18","volume":"127","author":"MH Dastjerdi","year":"2009","unstructured":"Dastjerdi, M. H. et al. Topical bevacizumab in the treatment of corneal neovascularization: results of a prospective, open-label, noncomparative study. Arch. Ophthalmol. (Chic., Ill.: 1960) 127, 381\u2013389 (2009).","journal-title":"Arch. Ophthalmol. (Chic., Ill.: 1960)"},{"key":"56461_CR37","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1001\/archopht.118.5.615","volume":"118","author":"RM Schiffman","year":"2000","unstructured":"Schiffman, R. M., Christianson, M. D., Jacobsen, G., Hirsch, J. D. & Reis, B. L. Reliability and validity of the Ocular Surface Disease Index. Arch. Ophthalmol. (Chic., Ill.: 1960) 118, 615\u2013621 (2000).","journal-title":"Arch. Ophthalmol. (Chic., Ill.: 1960)"},{"key":"56461_CR38","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/S1542-0124(12)70053-8","volume":"5","author":"DA Schaumberg","year":"2007","unstructured":"Schaumberg, D. A. et al. Development and validation of a short global dry eye symptom index. Ocul. Surf. 5, 50\u201357 (2007).","journal-title":"Ocul. Surf."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-56461-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-56461-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-56461-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T15:06:57Z","timestamp":1741705617000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-56461-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,4]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["56461"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-56461-1","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,4]]},"assertion":[{"value":"13 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Patent pending (UVJ, R.D., J.R., and M.A.). U.V.J. and R.D. have financial interests in OcuCell, Inc. This company is developing living ophthalmic cell-based therapies for treating eye disease. U.V.J. and R.D. interests were reviewed and are managed by Mass Eye and Ear Infirmary and Mass General Brigham in accordance with their competing interest policies. M.A. serves on the scientific advisory board for OcuCell, Inc. JR receives research funding from Kite\/Gilead, Novartis and Oncternal and serves on Scientific Advisory Boards for Astraveus, Garuda Therapeutics, LifeVault Bio, Smart Immune, Tolerance Bio, and TriArm Therapeutics. ARK, JY, AA, MM, LS, LKJ, MP, SL, AG, HN, KLS, DEHH, and HD declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1607"}}